Oculis Holding AG
NASDAQ:OCS · NASDAQ Global Market
-$0.28 today
Vol 0.75M · Avg 0.65M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-42.90%
Period High
$32.65
Period Low
$10.71
Latest
$11.22
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
AnaptysBio, Inc.
NASDAQ:ANAB
$2.40B
Kodiak Sciences Inc.
NASDAQ:KOD
$1.87B
UroGen Pharma Ltd.
NASDAQ:URGN
$1.58B
Mind Medicine (MindMed) Inc.
MNMD
$1.56B
Nurix Therapeutics, Inc.
NASDAQ:NRIX
$1.49B
Nektar Therapeutics
NASDAQ:NKTR
$1.17B
Xencor, Inc.
NASDAQ:XNCR
$942.65M
Phathom Pharmaceuticals, Inc.
NASDAQ:PHAT
$870.14M
Sana Biotechnology, Inc.
NASDAQ:SANA
$855.75M
BridgeBio Oncology Therapeutics Inc.
NASDAQ:BBOT
$610.42M
What is the latest OCS filing?
The latest filing shown is 6-K dated Jun 1, 2026.
How many recent filings does OCS have?
Intrinsic Alpha currently shows 20 recent filings for OCS.
Explore More
Continue the stock analysis
Jump to another research area for this company.